- $2.49bn
- $2.42bn
- $2.55bn
- 99
- 91
- 61
- 97
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,426 | 1,005 | 1,296 | 2,298 | 2,546 |
Cost of Revenue | |||||
Gross Profit | 1,406 | 965 | 1,192 | 2,116 | 2,252 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,266 | 970 | 1,160 | 1,481 | 1,762 |
Operating Profit | 160 | 35.4 | 136 | 817 | 785 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 98.1 | -9.24 | 35.4 | 568 | 778 |
Provision for Income Taxes | |||||
Net Income After Taxes | 93.6 | -13.2 | 34.1 | 467 | 656 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 76 | -9.76 | 34.1 | 467 | 656 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 76 | -9.76 | 34.1 | 467 | 656 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.6 | -1.04 | 0.627 | 12.4 | 19.6 |
Dividends per Share | |||||
Special Dividends per Share |